Fore Capital, LLC Crispr Therapeutics Ag Put Options Transaction History

Fore Capital, LLC

  • $297 Million
  • Q3 2025

Put Options

2 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2018

Feb 11, 2019
SELL
$22.73 - $42.34 $227,300 - $423,400
-10,000 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$44.35 - $65.71 $443,500 - $657,099
10,000 New
10,000 $444,000

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $4.32B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Fore Capital, LLC Portfolio

Follow Fore Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fore Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fore Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email